Tag ~therapeutics

Tag descriptions coming soon to Wherrelz News!


Juno Therapeutics agrees to pay 24M to stockholders in suit over disclosure of patient deaths

Headspace appoints former Intuit exec CeCe Morken as president and COO

BristolMyers Squibbs 74B acquisition of Juno parent Celgene puts Seattle biotech world on alert

YourChoice Therapeutics is developing unisex nonhormonal birth control

Startups Weekly: Ubers headlinegrabbing week and sextech at SXSW

Senti Bio raises 105 million for its new programmable biology platform and cancer therapies

Tech Moves: UW announces director for new DoD program Microsoft vet joins EQT and more

Meet the five Startup Battlefield finalists at Disrupt SF 2018

Seattle Genetics to acquire Cascadian Therapeutics for 614M to further bolster its cancer fight

Startup Aminex Therapeutics raises 10M begins clinical trials of immunotherapy treatment

SoftBank Vision Fund 2 leads 100 million Series C in digital therapeutics company Biofourmis

Osteoarthritis Therapeutics Market Demand Growth Challenges Industry Analysis And Forecasts to 2027

UK startup Healx to begin clinical trial on repositioned drug for Fragile X syndrome

Oviva grabs 80M for appdelivered healthy eating programs

Allegro 3D Receives Almost 1M in Grant Award to Develop Bioprinter

Longtime Juno Therapeutics CEO Hans Bishop leaves role after merger with Celgene

Top 10 Bioprinting Stories of 2020: Paving the Way to Future Organ Transplants

Microbiome Therapeutics Market Growth Factors Applications Regional Analysis Key Players and Forecasts by 2024

Week in Geek Podcast: A 9B biotech deal and a look at Pittsburghs tech renaissance

IPOs: A hot year for tech offerings shows deep economic disparities

Tech Moves: Microsofts new executive VP Puppet preps for IPO Vacasa adds tech vets to board

Cell therapies are giving Seattle an edge in biotech driving three acquisitions in under a month

Pioneering CRISPR researcher Jennifer Doudna is coming to Disrupt

How fourperson startup Luminopia is using TV to treat lazy eye

Seattle startup Accipiter Bio emerges with 127M and big pharma deals for AIdesigned proteins

Tech Moves: Amazon hires top doc Geir Hansen leaves SVB Acumatica board adds exMicrosoft Business Solutions chief

Global Actinic Keratosis Therapeutics Market 2019 By Demand End Users Manufacturers Growth and Forecast 2024

Celgene CEO: Treating cancer is becoming ironically easy now the problem is affordability

This cardiac care startup just landed 20M for virtual rehab services

Aquinox Pharmaceuticals set to acquire University of Wash spinout Neoleukin Therapeutics

Chronos Therapeutics Ltd Market Status and Outlook 2018

A look at 42 women in tech who crushed it in 2017

Digital therapeutics startup Neuroglee raises 10M to help people with neurodegenerative conditions

The US now seems to be pinning all of its hopes on COVID19 therapies and vaccines

Peptide Therapeutics Sales Market Therapeutics Assessment 2018 to 2025

From the scurfy mouse to the Nobel Prize: How a Seattle biotech pioneers long game paid off

Longtime Juno Therapeutics CEO Hans Bishop leaves role after acquisition by Celgene

Seattle biotech startup Good Therapeutics raises 11M to make smart cancer therapies

Capstone Therapeutics Corp CAPS Market Key Players Analysis and Forecast Report Till 2022

Organovos Merger Deal with Tarveda Falls Through for Now

Neuroglee gets 23 million to develop digital therapeutics for neurodegenerative diseases

3D Systems Pursuing Breakthrough Advances in Bioprinting Acquires Volumetric

3D Printings 2023 Startup Stars: Spotlight on InvestmentFueled Startups

Risks and rewards of digital therapeutics in treating mental disorders

Juno finds clinical success with cancer drug beats analyst expectations with 44M in revenue

Narcolepsy Therapeutics Market Estimated to Reach US 60471 Mn by 2022

3D Printed Vascularized Lung Models Push 3D Systems into Bioprinting

Nohla Therapeutics raises 45M gets new HQ as it moves novel leukemia treatment closer to market

BristolMyers Squibb exec on how can Seattle grow and keep big biotech companies

Marc Thurner Launches mimiX Biotherapeutics to Bioprint in the OR Using Sound